NASDAQ:OXFD - Oxford Immunotec Global SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$16.49 -0.38 (-2.25 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$16.87
Today's Range$16.26 - $16.94
52-Week Range$10.36 - $19.19
Volume115,100 shs
Average Volume132,297 shs
Market Capitalization$434.69 million
P/E Ratio-12.13
Dividend YieldN/A
Beta0.33

SEC Filings

Oxford Immunotec Global (NASDAQ:OXFD) SEC Filings

DateFilerForm TypeView
02/14/2019
12:25 PM
Alyeska Investment Group, L.P. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
View Filing
02/14/2019
10:14 AM
Consonance Capital Management LP (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
View Filing
02/14/2019
9:17 AM
Oxford Immunotec Global (Subject)
Polar Capital LLP (Filed by)
Form SC 13G/A
View Filing
02/12/2019
3:14 PM
Flynn James E (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
View Filing
02/05/2019
1:42 PM
Invesco Ltd. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
View Filing
02/01/2019
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
3:35 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
3:35 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/10/2019
3:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/08/2019
4:15 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
3:45 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
5:06 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
3:30 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
9:19 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
View Filing
11/09/2018
6:32 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
6:28 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
6:01 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/25/2018
3:31 PM
First Light Asset Management, LLC (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
View Filing
10/16/2018
7:46 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
View Filing
10/11/2018
4:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/27/2018
3:30 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/25/2018
8:55 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/20/2018
4:00 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/17/2018
3:56 PM
Oxford Immunotec Global (Filer)
Form CT ORDER
View Filing
09/10/2018
3:30 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/20/2018
8:24 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
View Filing
08/03/2018
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/31/2018
10:08 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/31/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
Walton Andrew Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
TOBIN JAMES R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
ROSENMAN HERM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:30 PM
Oxford Immunotec Global (Issuer)
RANDALL PATRICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:30 PM
Klausner Mark R. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:30 PM
BALTHROP PATRICK J (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:30 PM
ANDREWS RONALD ASBURY (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/20/2018
4:20 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/14/2018
3:39 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:01 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2018
9:08 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/01/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/12/2018
8:23 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/03/2018
9:39 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
View Filing
03/19/2018
4:13 PM
Linn Stefan C (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
4:13 PM
Altieri Richard M. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
4:12 PM
Oxford Immunotec Global (Issuer)
Wenstrup Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
4:12 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
4:12 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2018
9:01 AM
Oxford Immunotec Global (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/27/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/16/2018
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
1:30 PM
Alyeska Investment Group, L.P. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
View Filing
02/14/2018
10:55 AM
Oxford Immunotec Global (Subject)
Polar Capital LLP (Filed by)
Form SC 13G/A
View Filing
02/12/2018
2:37 PM
Invesco Ltd. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
View Filing
02/01/2018
4:08 PM
Flynn James E (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
View Filing
01/26/2018
3:30 PM
Altieri Richard M. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
8:00 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/22/2017
3:30 PM
Oxford Immunotec Global (Filer)
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/05/2017
4:00 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: Cost of Capital Explained

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel